I didn't think I needed to make a major case on this, given the major
overhaul of NIH's medical research protocols in response to charges
that "male as norm" studies were not responsive to women's needs in
regards to pharmaceuticals and cancer treatments. But then, maybe I
shouldn't have assumed.
Kathryn Aegis